Stock Fundamentals

Company Information

Company Name
Passage Bio Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US7027121000
CIK: 0001787297
CUSIP: 702712100
Currency: USD
Full Time Employees: 24
Phone: 267 866 0311
Fiscal Year End: December
IPO Date: Feb 28, 2020
Description:

Passage Bio, Inc., a genetic medicines company, develops gene therapies for central nervous system diseases. It develops PBFT02, a functional granulin (GRN) and gene encoding progranulin (PGRN) for the treatment of FTD caused by progranulin deficiency; PBGM01, a functional GLB1 gene encoding ß-galactosidase for infantile GM1; and PBKR03, for the treatment of Krabbe disease. The company develops PBML04 for the treatment of metachromatic leukodystrophy; PBAL05 for the treatment of amyotrophic lateral sclerosis; and other programs for huntington's disease. It has a strategic research collaboration with the Trustees of the University of Pennsylvania's Gene Therapy Program; and collaboration agreement, and a development services and clinical supply agreement with Catalent Maryland, Inc. Passage Bio, Inc. was incorporated in 2017 and is based in Philadelphia, Pennsylvania.

Address:

One Commerce Square, Philadelphia, PA, United States, 19103

Directors & Officers

Name Title Year Born
Dr. William Chou M.D. President, CEO & Director 1973
Ms. Kathleen Borthwick Senior VP, CFO, Principal Financial Officer & Principal Accounting Officer 1977
Mr. Stuart M. Henderson Chief Business Officer NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Jan 08, 2026 William Chou N/A Sale 4.08K $18.44 $75.16K
Sep 15, 2025 Lynx1 Capital Management Lp N/A Purchase 11.90K $6.99 $83.18K
Sep 12, 2025 Lynx1 Capital Management Lp N/A Purchase 19.78K $6.99 $138.28K
Sep 11, 2025 Lynx1 Capital Management Lp N/A Purchase 325.00 $6.96 $2.26K
Jul 24, 2025 Lynx1 Capital Management Lp N/A Purchase 66.42K $5.71 $379.28K
Jul 23, 2025 Lynx1 Capital Management Lp N/A Purchase 49.30K $5.74 $282.99K
Jul 22, 2025 Lynx1 Capital Management Lp N/A Purchase 13.12K $5.44 $71.39K
Jun 26, 2025 Orbimed Advisors Llc N/A Sale 10.66K $6.60 $70.37K
Jun 25, 2025 Orbimed Advisors Llc N/A Sale 6.94K $6.60 $45.80K
Jun 24, 2025 Orbimed Advisors Llc N/A Sale 11.58K $7.00 $81.06K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Lynx1 Capital Management, LP 623.70K Mar 31, 2026 19.44% $0.77 0.00%
Vestal Point Capital LP 305.00K Mar 31, 2026 9.51% $0.07 0.00%
Renaissance Technologies Corp 133.61K Mar 31, 2026 4.17% $0.00 22.48%
Eversept Partners, LP 131.58K Mar 31, 2026 4.10% $0.05 4.24%
Vanguard Group Inc 126.65K Dec 31, 2025 3.95% $0.00 8.22%
Vanguard Capital Management, LLC 113.96K Mar 31, 2026 3.55% $0.00 0.00%
Yiheng Capital LLC 86.10K Mar 31, 2026 2.68% $0.29 151.00%
Erste Asset Management GmbH 85.26K Mar 31, 2026 2.66% $0.00 0.00%
Ikarian Capital, LLC 68.12K Mar 31, 2026 2.12% $0.04 0.00%
Geode Capital Management, LLC 41.38K Mar 31, 2026 1.29% $0.00 31.80%
BlackRock Inc 28.60K Mar 31, 2026 0.89% $0.00 -1.07%
UBS Group AG 27.50K Mar 31, 2026 0.86% $0.00 1,807.14%
Acadian Asset Management LLC 24.20K Mar 31, 2026 0.75% $0.00 0.00%
Verdad Advisers, LP 22.13K Mar 31, 2026 0.69% $0.20 0.00%
Diadema Partners LP 19.53K Mar 31, 2026 0.61% $0.03 0.00%
BOOTHBAY FUND MANAGEMENT, LLC 18.87K Mar 31, 2026 0.59% $0.00 0.00%
Vanguard Fiduciary Trust Co 17.05K Mar 31, 2026 0.53% $0.00 0.00%
XTX Topco Ltd 12.63K Mar 31, 2026 0.39% $0.00 0.00%
Fiduciary Trust Co 10.75K Mar 31, 2026 0.34% $0.00 0.00%
Persistent Asset Partners Limited 4.96K Mar 31, 2026 0.15% $0.01 0.00%

Shares Statistics

Shares Outstanding: 3.21M
Shares Float: 2.89M
% Insiders: 40.70%
% Institutions: 5,841.00%
Short % Float: 4.74%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Total Stock Mkt Idx Inv 78.76K 2.46% ▲ 0.00% Apr 30, 2026
2 Vanguard Institutional Extnd Mkt Idx Tr 35.20K 1.10% ▲ 0.00% Apr 30, 2026
3 Fidelity Extended Market Index 22.19K 0.69% ▼ 0.36% Apr 30, 2026
4 Fidelity Total Market Index 6.43K 0.20% ▲ 0.00% Apr 30, 2026
5 Spartan Extended Market Index Pool F 4.90K 0.15% ▲ 1.68% Apr 30, 2026
6 Fidelity Series Total Market Index 4.78K 0.15% ▲ 0.00% Apr 30, 2026
7 Blackrock Extended Mkt Fund CF 4.31K 0.13% ▲ 0.00% Apr 30, 2026
8 Extended Equity Market Fund B 4.31K 0.13% ▲ 0.00% Dec 31, 2025
9 Extended Equity Market Fund E 4.31K 0.13% ▲ 0.00% Dec 31, 2025
10 Northern Trust Extended Eq Market Idx 3.81K 0.12% ▲ 0.00% Mar 31, 2026

Valuation Metrics

Enterprise Value: $-9.94M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $17.64M
EBITDA: $-36.92M
Book Value: $3.66
Earnings/Share: $-11.84
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -38.35%
ROE (TTM): -128.90%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 2.07x 0.19x 0.70x N/A -0.08x
2024-12-31 4.07x 0.06x 0.40x N/A -0.06x
2023-12-31 7.22x 0.03x 0.26x N/A -0.03x
2022-12-31 10.74x 0.02x 0.17x -60.99x -0.02x
2021-12-31 11.02x 0.00x 0.10x -541.48x 0.00x
2020-12-31 14.98x 0.00x 0.07x -168.51x 0.00x
2019-12-31 45.04x 0.00x 0.02x -4.40x 0.00x
2018-12-31 108.79x 0.00x 1.36x -19.35x 0.00x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about PASG.US!